Gabriela Silva obtained an M.S. (1994) in Biology from Lomonosov Moscow State University (Russia) and a Ph.D. in Biology (2001) from Instituto de Tecnologia Química e Biológica (Portugal). From 2002 to 2014, she developed research in inflammation and cancer on projects aiming to understand the mechanisms regulating disease and the therapeutic actions of epigenetic agents. She joined iBET in 2014, where she has been involved in projects on the development of antibodies, adeno-associated viral vectors for gene therapy, and the role of Notch pathway ligands in cancer. Her research interests include understanding the mechanisms that govern diseases and developing associated therapeutics. Orcid ID link: https://orcid.org/0000-0002-4004-9904